1Patrick J. Creaven,John E. Plager,Sherry Dupere,Robert P. Huben,Hiroshi Takita,Arnold Mittelman,April Proefrock. Phase I clinical trial of recombinant human tumor necrosis factor[J] 1987,Cancer Chemotherapy and Pharmacology(2):137～144
2Katsuyuki Haranaka,Nobuko Satomi,Akiko Sakurai,Ruriko Haranaka,Naoko Okada,Mosaburo Kobayashi. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs[J] 1985,Cancer Immunology Immunotherapy(1):1～5
4Phlip R, Epstein L B. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, r-interferon and interleukin-1 [ J ]. Nature ( London) , 1986,323 : 86-93.
5Tracey K J. Cachectin/tumor necrosts factor induces cachexia,anemia and inflammation [ J ]. Exp Med, 1988,167 : 1211-1217.
6Tracey K J. Shock and tissue injury induced by recombinant human cachectin[ J]. Science, 1986,234:470-475.
7Prpic V. Effect of bacterial lipopolysaccharide on hydrolysis of phosphatidylinositol-4,5-biosphosphate in murine peritoneal macrophages [ J ]. Immunol, 1987, 137 : 526-533.
8Weiel J E. LPS induces phosphate loading of protein in murine peritoneal maerophages [ J ]. Immunol, 1986,136 :3012-3016.
9Wright B . Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists[ J]. Cell Immunol, 1985,95 : 46 -51.
